2161364-69-6

2161364-69-6 structure
2161364-69-6 structure
  • Name: HBV-IN-25
  • Chemical Name: HBV-IN-25
  • CAS Number: 2161364-69-6
  • Molecular Formula: C18H14ClNO4
  • Molecular Weight: 343.76
  • Catalog: Signaling Pathways Anti-infection HBV
  • Create Date: 2022-10-21 19:25:05
  • Modify Date: 2024-01-31 15:06:43
  • HBV-IN-25 is a good potency, orally active novel HBV cccDNA reducer. HBV-IN-25 has anti-HBeAg potency and anti-HBV activity with IC50 values of 0.58 μM and 1.15 μM, respectively. HBV-IN-25 has good aqueous solubility (LYSA>452 μg/mL) and good PK property with no cellular toxicity[1].

Name HBV-IN-25
Description HBV-IN-25 is a good potency, orally active novel HBV cccDNA reducer. HBV-IN-25 has anti-HBeAg potency and anti-HBV activity with IC50 values of 0.58 μM and 1.15 μM, respectively. HBV-IN-25 has good aqueous solubility (LYSA>452 μg/mL) and good PK property with no cellular toxicity[1].
Related Catalog
Target

IC50: 0.58 μM (anti-HBeAg); 1.15 μM (anti-HBV)[1].

In Vitro HBV-IN-25 (8-50 μM, 5 days) has anti-HBeAg potency with an IC50 value of 0.58 μM. HBV-IN-25 (8-50 μM, 5 days) has the anti-HBV activity in PHH is maintained or slightly decreased with IC50 value of 1.15 μM[1].
In Vivo HBV-IN-25 (oral, 5, 20, 100, 300 mg/kg, single) has good PK property, and also shows excellent efficacy in significantly reducing HBV antigens, DNA, and intrahepatic cccDNA levels[1]. Pharmacokinetic Parameters of HBV-IN-25 inHBVcircle mouse model (oral, 5, 20, 100, 300 mg/kg, single)[1]. Dose Terminal body weight % versus day 1 Spinal cord inflammation Foci per 20 cells Spinal cord demyelination Score 0–5 Spinal cord apoptotic cells Count per section PK parameter 5 mg/kg PO 20 mg/kg PO 100 mg/kg PO 300 mg/kg PO Cmax(ng/kg) 828 8157 32200 59900 Tmax(ng/kg) 0.25 0.5 0.5 2.67 AUC0−∞(ng h/mL) 857 11,818 119,960 453,367 t1/2(h) 3.46 3.45 1.82 dose-normalized Cmax[(ng/mL)/(mg/kg)] 166 408 322 200 Dose-normalized AUC0−24h [(ng h/mL)/(mg/kg)] 171 591 1200 1511 Animal Model: HBVcircle mouse model[1] Dosage: 5, 20, 100, 300 mg/kg Administration: oral, 5, 20, 100, 300 mg/kg, single Result:
References

[1]. Dongdong Chen, et al. Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection. J Med Chem. 2022 Aug 16.

Molecular Formula C18H14ClNO4
Molecular Weight 343.76
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.